We are live on ! Find out more
MIST icon

Milestone Pharmaceuticals
MIST

47 hedge funds and large institutions have $203M invested in Milestone Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

950% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 2

75% more capital invested

Capital invested by funds: $116M → $203M (+$87.4M)

62% more funds holding

Funds holding: 29 → 47 (+18)

27% more call options, than puts

Call options by funds: $11.6M | Put options by funds: $9.09M

5.49% more ownership

Funds ownership: 69.58% → 75.07% (+5.5%)

25% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 12

Holders
47
Holders Change
+18
Holders Change %
+62.07%
% of All Funds
0.81%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.05%
New
21
Increased
9
Reduced
12
Closed
2
Calls
$11.6M
Puts
$9.09M
Net Calls
+$2.48M
Net Calls Change
+$988K

Top Buyers

1
VA
VR Adviser
New York
+$18.4M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$8.5M
3
GPP
Great Point Partners
Connecticut
+$5.12M
4
PBA
Paradigm Biocapital Advisors
New York
+$4.81M
5
LPC
Lion Point Capital
New York
+$4.62M

Top Sellers

1
BC
Boxer Capital
California
-$11.7M
2
NHAS
Novo Holdings A/S
Denmark
-$4.02M
3
IC
Ikarian Capital
Texas
-$3.97M
4
Millennium Management
Millennium Management
New York
-$3.23M
5
PVI
Pura Vida Investments
New York
-$2.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$426K +$213K +28,075 +154%
LP
27
LMR Partners
United Kingdom
$354K +$203K +26,763 +228%
Marshall Wace
28
Marshall Wace
United Kingdom
$284K +$234K +30,898 New
FAM
29
Fred Alger Management
New York
$245K +$202K +26,672 New
CM
30
Caption Management
Oklahoma
$233K +$192K +25,378 New
State Street
31
State Street
Massachusetts
$202K +$2.94K +388 +2%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$161K – – –
EGM
33
Engineers Gate Manager
New York
$108K +$89.5K +11,800 New
CSS
34
Cubist Systematic Strategies
Connecticut
$107K +$88K +11,600 New
SFI
35
Susquehanna Fundamental Investments
Pennsylvania
$106K +$87.2K +11,499 New
FDCDDQ
36
Federation des caisses Desjardins du Quebec
Quebec, Canada
$96.5K – – –
Group One Trading
37
Group One Trading
Illinois
$39K +$32.2K +4,248 New
CG
38
Cutler Group
California
$36K +$29.9K +3,937 New
UBS Group
39
UBS Group
Switzerland
$31K +$17.5K +2,304 +227%
National Bank of Canada
40
National Bank of Canada
Quebec, Canada
$26K -$90.7K -11,962 -81%
Osaic Holdings
41
Osaic Holdings
Arizona
$24K -$2.1K -277 -10%
CAC
42
Cowen and Company
New York
$20K +$106K +14,000 New
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$18K -$125K -16,500 -89%
CL
44
CSS LLC
Illinois
$9K +$7.64K +1,008 New
PNC Financial Services Group
45
PNC Financial Services Group
Pennsylvania
$1K +$1.04K +137 New
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$446 +$365K +48,100 New
O
47
OrbiMed
New York
– -$11.2K -1,817,521 Closed
Acadian Asset Management
48
Acadian Asset Management
Massachusetts
– -$84K -13,717 Closed
BlackRock
49
BlackRock
New York
– +$38 +5 New
1
2

MIST Hedge Fund Activity: Q3 2022 in Review

47 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Milestone Pharmaceuticals (MIST) for Q3 2022, worth a combined $203M — up 75% from $116M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new MIST positions and 2 closed out — a net gain of 19 holders — while 9 added to existing stakes and 12 trimmed.

The largest buyer was VR Adviser, opening a new position worth an estimated $18.4M. The largest seller was Boxer Capital, cutting an estimated $11.7M.

  • 47 institutional investors held Milestone Pharmaceuticals (MIST) as of Q3 2022, up from 29 in Q2 2022.
  • Funds reported $203M of Milestone Pharmaceuticals stock for Q3 2022, up 75% quarter-over-quarter.
  • 21 funds opened new Milestone Pharmaceuticals positions in Q3 2022 and 2 closed out, a net change of +19 holders.
  • The largest Milestone Pharmaceuticals buyer in Q3 2022 was VR Adviser, an estimated $18.4M added.
  • The largest Milestone Pharmaceuticals seller in Q3 2022 was Boxer Capital, an estimated $11.7M sold.

Based on aggregated 13F filings for Q3 2022.